Shuanglin Peng

565 total citations
22 papers, 453 citations indexed

About

Shuanglin Peng is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Shuanglin Peng has authored 22 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in Shuanglin Peng's work include Mesenchymal stem cell research (6 papers), RNA Interference and Gene Delivery (4 papers) and Autophagy in Disease and Therapy (4 papers). Shuanglin Peng is often cited by papers focused on Mesenchymal stem cell research (6 papers), RNA Interference and Gene Delivery (4 papers) and Autophagy in Disease and Therapy (4 papers). Shuanglin Peng collaborates with scholars based in China and Japan. Shuanglin Peng's co-authors include Jingang Xiao, Yunfeng Lin, Dexuan Xiao, Sirong Shi, Yanjing Li, Lang Wang, Xiaoxiao Cai, Yue Sun, Taoran Tian and Dan Zhao and has published in prestigious journals such as Chemical Engineering Journal, ACS Applied Materials & Interfaces and Science Advances.

In The Last Decade

Shuanglin Peng

20 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuanglin Peng China 12 256 139 64 59 41 22 453
Yangxue Yao China 11 336 1.3× 137 1.0× 75 1.2× 47 0.8× 56 1.4× 25 576
Youngmi Ji United States 14 273 1.1× 108 0.8× 87 1.4× 80 1.4× 50 1.2× 24 640
Binxi Li China 7 152 0.6× 186 1.3× 43 0.7× 44 0.7× 102 2.5× 10 391
Lvyuan Li China 8 204 0.8× 113 0.8× 108 1.7× 24 0.4× 48 1.2× 13 346
Yanxin An China 11 177 0.7× 188 1.4× 107 1.7× 60 1.0× 56 1.4× 16 482
Mateusz Sikora Poland 11 129 0.5× 83 0.6× 81 1.3× 26 0.4× 25 0.6× 19 291
Thanapat Pongkulapa United States 10 213 0.8× 197 1.4× 41 0.6× 50 0.8× 66 1.6× 14 452
Thomas Cordonnier France 11 219 0.9× 154 1.1× 74 1.2× 30 0.5× 90 2.2× 15 532
Rongtai Zuo China 10 137 0.5× 91 0.7× 57 0.9× 33 0.6× 44 1.1× 19 346

Countries citing papers authored by Shuanglin Peng

Since Specialization
Citations

This map shows the geographic impact of Shuanglin Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuanglin Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuanglin Peng more than expected).

Fields of papers citing papers by Shuanglin Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuanglin Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuanglin Peng. The network helps show where Shuanglin Peng may publish in the future.

Co-authorship network of co-authors of Shuanglin Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Shuanglin Peng. A scholar is included among the top collaborators of Shuanglin Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuanglin Peng. Shuanglin Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Ting, Qilin Li, Qilin Li, et al.. (2025). Activation of autophagy mediated by PI3K/Akt/mTOR signalling cascade alleviates impaired adipose‐derived stem cell osteogenesis in a diabetic microenvironment. British Journal of Pharmacology. 182(15). 3522–3538. 3 indexed citations
2.
Peng, Shuanglin, Zhong Zhang, Yang Li, et al.. (2025). RPA1 protects DNA damage–induced PANoptosis in limb development. Science Advances. 11(34). eadw2756–eadw2756. 1 indexed citations
3.
Tang, Hui, Zhenzhen Chen, Lu Zeng, et al.. (2025). Accelerating Bone Healing With METTL3 Overexpressed Adipose‐Derived Stem Cells in Osteoporotic Rats. Cell Proliferation. 58(9). e70029–e70029.
5.
Fu, Ting, et al.. (2023). Advanced glycation end products inhibit the osteogenic differentiation potential of adipose-derived stem cells in mice through autophagy. Cellular Signalling. 108. 110694–110694. 6 indexed citations
6.
Bai, Long, et al.. (2023). Hydrogel Drug Delivery Systems for Bone Regeneration. Pharmaceutics. 15(5). 1334–1334. 42 indexed citations
7.
Peng, Shuanglin, Qing Li, Pengcheng Rao, et al.. (2023). Methyltransferase‐like 3 modulates osteogenic differentiation of adipose‐derived stem cells in osteoporotic rats. The Journal of Gene Medicine. 25(5). e3481–e3481. 9 indexed citations
8.
Zhao, Dan, Dexuan Xiao, Mengting Liu, et al.. (2022). Tetrahedral framework nucleic acid carrying angiogenic peptide prevents bisphosphonate-related osteonecrosis of the jaw by promoting angiogenesis. International Journal of Oral Science. 14(1). 23–23. 42 indexed citations
9.
Zhang, Maorui, Bo Yang, Shuanglin Peng, & Jingang Xiao. (2021). Metformin Rescues the Impaired Osteogenesis Differentiation Ability of Rat Adipose-Derived Stem Cells in High Glucose by Activating Autophagy. Stem Cells and Development. 30(20). 1017–1027. 18 indexed citations
10.
Li, Yanjing, Shaojingya Gao, Sirong Shi, et al.. (2021). Tetrahedral Framework Nucleic Acid-Based Delivery of Resveratrol Alleviates Insulin Resistance: From Innate to Adaptive Immunity. Nano-Micro Letters. 13(1). 186–186. 63 indexed citations
11.
Liao, Jinfeng, Taoran Tian, Sirong Shi, et al.. (2021). Broadening the biocompatibility of gold nanorods from rat to Macaca fascicularis: advancing clinical potential. Journal of Nanobiotechnology. 19(1). 195–195. 7 indexed citations
12.
Peng, Shuanglin, Sirong Shi, Gang Tao, et al.. (2021). JKAMP inhibits the osteogenic capacity of adipose-derived stem cells in diabetic osteoporosis by modulating the Wnt signaling pathway through intragenic DNA methylation. Stem Cell Research & Therapy. 12(1). 120–120. 22 indexed citations
13.
Li, Qirong, Ronghui Zhou, Yue Sun, et al.. (2021). Synthesis and Antitumor Application of Antiangiogenetic Gold Nanoclusters. ACS Applied Materials & Interfaces. 13(10). 11708–11720. 17 indexed citations
14.
Li, Yanjing, Shaojingya Gao, Sirong Shi, et al.. (2021). Correction to: Tetrahedral Framework Nucleic Acid‑Based Delivery of Resveratrol Alleviates Insulin Resistance: From Innate to Adaptive Immunity. Nano-Micro Letters. 13(1). 3 indexed citations
15.
Peng, Shuanglin, et al.. (2021). [Osteogenic Capacity and Mettl14 and Notch1 Expression of Adipose-Derived Stem Cells from Osteoporotic Rats].. PubMed. 52(3). 423–429. 3 indexed citations
16.
Xiao, Dexuan, Yanjing Li, Sirong Shi, et al.. (2021). Tetrahedral framework nucleic acids regulate osteogenic differentiation potential of osteoporotic adipose-derived stem cells. Chinese Chemical Letters. 33(5). 2517–2521. 20 indexed citations
17.
Zhao, Dan, Mengting Liu, Jiajie Li, et al.. (2021). Angiogenic Aptamer-Modified Tetrahedral Framework Nucleic Acid Promotes Angiogenesis In Vitro and In Vivo. ACS Applied Materials & Interfaces. 13(25). 29439–29449. 34 indexed citations
18.
Peng, Shuanglin, Sirong Shi, Dan Zhao, et al.. (2021). LncRNA‐AK137033 inhibits the osteogenic potential of adipose‐derived stem cells in diabetic osteoporosis by regulating Wnt signaling pathway via DNA methylation. Cell Proliferation. 55(1). e13174–e13174. 30 indexed citations
19.
Li, Yanjing, Ronghui Zhou, Dexuan Xiao, et al.. (2020). Polypeptide uploaded efficient nanophotosensitizers to overcome photodynamic resistance for enhanced anticancer therapy. Chemical Engineering Journal. 403. 126344–126344. 35 indexed citations
20.
Zhang, Qi, Shiyu Lin, Lang Wang, et al.. (2020). Tetrahedral framework nucleic acids act as antioxidants in acute kidney injury treatment. Chemical Engineering Journal. 413. 127426–127426. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026